Table3_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table9_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Image1_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.tif by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table7_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table6_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table11_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table8_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table5_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table10_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table1_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Data sources and descriptions. by Zeduo Zou (21672789)

“…As the results show, during the study period: (1) Temporal Trends: annual PM2.5 concentrations exhibited significant declines, with BTH decreasing from 1004.71 μg/m³ (2006) to 528 μg/m³ (2020), YRD from 1434.81 μg/m³ (2008) to 621 μg/m³, and PRD from 405.02 μg/m³ (2007) to 292 μg/m³. …”

Table4_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Image2_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.tif by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Molecular signatures underlying multisensory gamma stimulation-associated cognitive benefits in the hippocampus. by Md Rezaul Islam (19649494)

“…<p><b>A)</b> Experimental scheme for the single nuclei RNA-seq experiment in Ts65Dn mice <b>B)</b> Unbiased clustering of hippocampal snRNA-seq data for 15884 nuclei represented on a UMAP. …”

Table 1_Serum levels of interleukin-17, -18, -22, and -25 in patients with bullous pemphigoid before and after treatment.xlsx by Xinyi Hong (8181177)

“…A binary multivariate logistic regression analysis indicated the statistically significant effect of IL-18, IL-25, or EOS on BP (p < 0.001). …”

Table 3_An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990–2021.xlsx by Zhuowen Hu (20431616)

“…High Body Mass Index (BMI) is a significant risk factor, contributing substantially to GBTC mortality and Disability-Adjusted Life Years (DALYs). …”

Image 11_An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990–2021.tif by Zhuowen Hu (20431616)

“…High Body Mass Index (BMI) is a significant risk factor, contributing substantially to GBTC mortality and Disability-Adjusted Life Years (DALYs). …”

Image 12_An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990–2021.tif by Zhuowen Hu (20431616)

“…High Body Mass Index (BMI) is a significant risk factor, contributing substantially to GBTC mortality and Disability-Adjusted Life Years (DALYs). …”

Image 10_An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990–2021.tif by Zhuowen Hu (20431616)

“…High Body Mass Index (BMI) is a significant risk factor, contributing substantially to GBTC mortality and Disability-Adjusted Life Years (DALYs). …”

Image 1_An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990–2021.tif by Zhuowen Hu (20431616)

“…High Body Mass Index (BMI) is a significant risk factor, contributing substantially to GBTC mortality and Disability-Adjusted Life Years (DALYs). …”